R&D Blueprint
The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises.

Key actions by disease

Related activities

Documents

All →

This protocol was written in accordance with the trial design and drug selection recommendations from the Filovirus therapeutics working group at WHO....

WHO Target Product Profiles for mpox Vaccines

This document describes the preferred and minimally acceptable profiles for human vaccines for all clades of mpox.  All vaccines considered for use...

A coordinated research roadmap Monkeypox virus-Immediate research next steps to contribute to control the outbreak-Thumb

A scientific conference was held on August 29-30, 2024. It focused on aligning mpox research with outbreak response goals. This meeting was part of a comprehensive effort...

Mpox Vaccine Tracker: List of vaccine candidates in research & developmentSmallpox vaccines have currently have been repurposed and recommended for...

Publications

All →

This large, international, randomized controlled clinical trial is designed to enable an expeditious, agile and concurrent evaluation of the benefits and...

There has been some suggestions for the inclusion of Favipiravir in the Solidarity trial. 

Currently, there are no licensed vaccines for the prevention of COVID 19. While efforts continue to develop effective vaccines, it is pertinent to examine...

Related health topics